General Information of the Compound
| Compound ID |
CP0942622
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
N-((5-(4-ethoxybenzyl)-1,3,4-oxadiazol-2-yl)methyl)-N-(3-chloro-2-methylphenyl)-4-methylbenzenesulfonamide
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C26H26ClN3O4S
|
||||||||||||||||||
| Molecular Weight |
512.031
|
||||||||||||||||||
| Canonical SMILES |
CCOc1ccc(Cc2nnc(CN(c3cccc(Cl)c3C)S(=O)(=O)c3ccc(C)cc3)o2)cc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C26H26ClN3O4S/c1-4-33-21-12-10-20(11-13-21)16-25-28-29-26(34-25)17-30(24-7-5-6-23(27)19(24)3)35(31,32)22-14-8-18(2)9-15-22/h5-15H,4,16-17H2,1-3H3
Show/Hide
|
||||||||||||||||||
| InChIKey |
VVMLMYHDJFJXNI-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound